| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |